Channing Der guides the Guardian through the history of the "Undruggable RAS Mutation."
This Friday, October 16th, Der/Cox lab member Jane Lee will present at the Pharmacology Student Zoom Seminar. Her presentation will be on “Discovering novel therapies in combination with ERK MAPK and/or autophagy inhibition in pancreatic cancer". Come out on Friday at 12:00 pm to support Jane!
For the month of November, the Der and Cox labs have gone purely purple. The dress code is inspired by the official pancreatic cancer ribbon and is worn all month to bring awareness to pancreatic cancer. See ABC 11's interview with Dr. Jen Jen Yeh and Dr. Kirsten Bryant here. Photos courtesy of the UNC … Continue reading Der Lab Goes Purple for Pancreatic Awareness
A new study from University of North Carolina Lineberger Comprehensive Cancer Center researchers reveals important findings about how a common genetic mutation in pancreatic cancer works to drive tumor growth. In the journal Cancer Discovery, researchers led by UNC Lineberger’s Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of a particular mutation … Continue reading Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment
August 5, 2019 Today, the Der and Cox labs were visited by the Blue Ribbon group of Wilmington, NC. The Blue Ribbon Run raises money for the Julie M. Brown and Christina M. Gianoplus Fund for Colon Cancer Research from Wilmington, NC. Members of the group included Ana Boudreau, event founder, and Sarah Powell, a … Continue reading Der Lab Blue Ribbon Tour 2019
Published March 4th, 2019 in Nature Medicine, two new studies describe a combination approach to target the KRAS signaling pathway and a process called autophagy as a way to treat pancreatic cancer patients. Sources: Two Studies Point to New Combination Treatment for Pancreatic Cancer – Pancreatic Cancer Action Network, 3/4/2019 Advancements in Promising New Pancreatic … Continue reading Dr. Kirsten Bryant’s recent publication in Nature Medicine stimulates excitement for a new therapeutic strategy for pancreatic cancer.
The National Cancer Institute’s Outstanding Investigator Award supports accomplished leaders in cancer research. November 13, 2018 UNC Lineberger’s Channing Der, PhD, has been awarded the National Cancer Institute’s Outstanding Investigator Award, which supports accomplished leaders in cancer research who are working on science with breakthrough potential. The award provides up to $600,000 in direct costs per … Continue reading UNC Lineberger Writes: Der receives NCI Outstanding Investigator Award
The NCI Outstanding Investigator Award (OIA) supports investigators with outstanding records of productivity in cancer research by providing extended funding stability and encouraging investigators to continue or embark on projects of unusual potential in cancer research. The research funded will focus on exploiting novel protein kinases that regulate MYC protein stability to cause MYC loss, … Continue reading Channing Der Granted 2018 NCI Outstanding Investigator Award
UNC's Running RAScals (aka the Der Lab at UNC Lineberger & Friends) participated in this year’s PanCAN #PurpleStride run on Saturday, April 21st. This 5k run raises money to support the Pancreatic Cancer Action Network. The team, organized by Kirsten Bryant, raised $10,839 to support Pancreatic Cancer Research, coming in Fifth in overall fundraising! This was the Der Lab's fifth … Continue reading PurpleStride Raleigh-Durham 2018: Running RAScals
Rick and Donna Martinez have a morning live interview show featuring conversations with community personalities and leaders about issues that impact you. We are happy to share the March 1, 2018 radio podcast with our own Pancreatic Cancer Experts Channing Der, PhD and Kirsten Bryant, PhD. This interview discusses common perceptions of Pancreatic Cancer; Symptoms … Continue reading News radio 680 WPTF on Pancreatic Cancer